Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    17613449 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting The MetNET-2 Trial
Condition: Neuroendocrine Tumors
Intervention: Drug: Lanreotide and Metformin
2 Recruiting ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Saxagliptin;   Drug: Dapagliflozin;   Drug: Placebo
3 Unknown  Impact of CAMP in an Ambulatory Renal Clinic
Condition: Chronic Kidney Disease
Intervention: Other: Pharmacy care arm

Indicates status has not been verified in more than two years